Skip to main content
. 2021 Apr 22;12:676396. doi: 10.3389/fphar.2021.676396

TABLE 1.

Prophylactic treatment with RRx-001 Reduced Pancytopenia after Sublethal Irradiation.

Time after radiation Treatment group WBC (×103 cells/µL) ALC (×103 cells/µL) ANC (×103 cells/µL) Platelets (×103 cells/µL) % Hematocrit % Reticulocytes
Average days 2, 7, 14, 21, 28 Vehicle + sham 5.01 ± 0.31 3.75 ± 0.26 0.91 ± 0.06 913.66 ± 52.55 41.59 ± 0.44 2.54 ± 0.07
RRx-001 + Sham 4.73 ± 0.27 3.38 ± 0.21 0.97 ± 0.06 **1,067.73 ± 32.26 41.66 ± 0.45 2.62 ± 0.07
Day 2 Vehicle +7 Gy 0.82 ± 0.14 0.07 ± 0.01 0.67 ± 0.13 863.00 ± 88.08 39.27 ± 0.85 ND
RRx-001 + 7 Gy 1.38 ± 0.20 0.07 ± 0.01 1.13 ± 0.20 979.00 ± 40.35 41.07 ± 0.82 ND
Day 7 Vehicle +7 Gy 0.18 ± 0.05 0.08 ± 0.03 0.07 ± 0.01 93.33 ± 16.29 30.08 ± 0.99 0.03 ± 0.01
RRx-001 + 7 Gy 0.21 ± 0.03 0.04 ± 0.00 *0.11 ± 0.02 *133.40 ± 16.74 31.36 ± 1.00 0.05 ± 0.01
Day 14 Vehicle +7 Gy 0.25 ± 0.03 0.18 ± 0.02 0.06 ± 0.01 78.33 ± 9.97 25.27 ± 0.62 1.62 ± 0.28
RRx-001 + 7 Gy *0.70 ± 0.20 *0.49 ± 0.14 *0.14 ± 0.03 *143.25 ± 36.54 *28.38 ± 0.55 *4.05 ± 1.08
Day 21 Vehicle +7 Gy 1.19 ± 0.13 0.51 ± 0.08 0.52 ± 0.04 371.60 ± 66.29 40.40 ± 0.36 7.08 ± 1.59
RRx-001 + 7 Gy 1.11 ± 0.11 0.46 ± 0.03 0.50 ± 0.07 448.33 ± 40.37 39.38 ± 1.58 6.06 ± 1.03
Day 28 Vehicle +7 Gy 2.20 ± 0.34 0.77 ± 0.19 1.17 ± 0.20 595.50 ± 135.15 35.83 ± 2.18 2.62 ± 0.09
RRx-001 + 7 Gy 2.69 ± 0.33 1.18 ± 0.32 1.09 ± 0.11 497.60 ± 116.12 39.02 ± 1.57 *3.66 ± 0.40

Values are the mean ± SEM (n = 2–3 mice/group/time point); ND, not determined. *p < 0.05 comparing the irradiated groups/time point. Significance was determined using a parametric test consisting of a general linear model ANOVA and the Kruskal–Wallis nonparametric test. **p < 0.01 comparing the nonirradiated groups combining days 2, 7, 14, 21 and 28. Significance was determined using the longitudinal mixed model repeated measures analysis. This experiment was performed in duplicate.